Stay updated with breaking news from Safety Tolerability. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Disease Landscape Insights equips healthcare pioneers with the tools to combat ringworm early stages, providing in-depth diagnostic, treatment, and market...
From pfizer's phase, 1, 2, 3 results. it was basically looking at safety tolerability and immunogenecity, meaning what did these kids elicit. they received about a third of the dose of adults and neutralizing antibodies were comparable to those in the older age group. what that as led researchers to suggest, is this vaccine at this dose should be a safe and effective vaccine for this age group, but to make that determination, hallie, will require that pfizer files for a formal eua to the fda, who will then review it over the next number of weeks and their advisory committee will meet,